The EarlyCDT Lung test is a commercially available blood test, based on ELISA principles, that measures a panel of seven tumor-associated autoantibodies: p53, NY-ESO-1, CAGE, GBU4–5, SOX2, HuD, and MAGE A4 [18]. Here, TP53 is linked to neoplasm.